Brief

The Drug Alert for October 2024 identifies multiple Not of Standard Quality (NSQ) drugs, revealing critical failures in sterility, assay, dissolution, particulate matter, and misbranding. The CDSCO’s monthly regulatory surveillance ensures that substandard pharmaceuticals are flagged for corrective action, emphasizing the importance of strict quality control in drug manufacturing.

This content is restricted.

Highlights content goes here...

This content is restricted.

Central Drugs Standard Control Organization (CDSCO)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
$125 / month OR $1250 / year
Features
Best for: Researchers, Legal professionals, Academics
Enterprise Plan
Contact for Pricing
Features
Best for: Law Firms, Corporations, Government Bodies